S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   357.55 (-0.20%)
AAPL   171.12 (-0.05%)
MSFT   315.68 (-0.02%)
META   300.70 (+0.16%)
GOOGL   130.31 (-0.42%)
AMZN   126.90 (-0.17%)
TSLA   240.58 (-3.85%)
NVDA   438.16 (+0.73%)
NIO   8.92 (-1.33%)
BABA   86.75 (+0.01%)
AMD   102.65 (-0.17%)
T   15.01 (-0.07%)
F   12.34 (-0.64%)
MU   68.03 (+0.00%)
CGC   0.78 (-0.97%)
GE   110.00 (-0.50%)
DIS   80.82 (-0.28%)
AMC   8.05 (+0.75%)
PFE   33.13 (-0.12%)
PYPL   58.65 (+0.33%)
NFLX   377.00 (-0.16%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   357.55 (-0.20%)
AAPL   171.12 (-0.05%)
MSFT   315.68 (-0.02%)
META   300.70 (+0.16%)
GOOGL   130.31 (-0.42%)
AMZN   126.90 (-0.17%)
TSLA   240.58 (-3.85%)
NVDA   438.16 (+0.73%)
NIO   8.92 (-1.33%)
BABA   86.75 (+0.01%)
AMD   102.65 (-0.17%)
T   15.01 (-0.07%)
F   12.34 (-0.64%)
MU   68.03 (+0.00%)
CGC   0.78 (-0.97%)
GE   110.00 (-0.50%)
DIS   80.82 (-0.28%)
AMC   8.05 (+0.75%)
PFE   33.13 (-0.12%)
PYPL   58.65 (+0.33%)
NFLX   377.00 (-0.16%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   357.55 (-0.20%)
AAPL   171.12 (-0.05%)
MSFT   315.68 (-0.02%)
META   300.70 (+0.16%)
GOOGL   130.31 (-0.42%)
AMZN   126.90 (-0.17%)
TSLA   240.58 (-3.85%)
NVDA   438.16 (+0.73%)
NIO   8.92 (-1.33%)
BABA   86.75 (+0.01%)
AMD   102.65 (-0.17%)
T   15.01 (-0.07%)
F   12.34 (-0.64%)
MU   68.03 (+0.00%)
CGC   0.78 (-0.97%)
GE   110.00 (-0.50%)
DIS   80.82 (-0.28%)
AMC   8.05 (+0.75%)
PFE   33.13 (-0.12%)
PYPL   58.65 (+0.33%)
NFLX   377.00 (-0.16%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   357.55 (-0.20%)
AAPL   171.12 (-0.05%)
MSFT   315.68 (-0.02%)
META   300.70 (+0.16%)
GOOGL   130.31 (-0.42%)
AMZN   126.90 (-0.17%)
TSLA   240.58 (-3.85%)
NVDA   438.16 (+0.73%)
NIO   8.92 (-1.33%)
BABA   86.75 (+0.01%)
AMD   102.65 (-0.17%)
T   15.01 (-0.07%)
F   12.34 (-0.64%)
MU   68.03 (+0.00%)
CGC   0.78 (-0.97%)
GE   110.00 (-0.50%)
DIS   80.82 (-0.28%)
AMC   8.05 (+0.75%)
PFE   33.13 (-0.12%)
PYPL   58.65 (+0.33%)
NFLX   377.00 (-0.16%)

Zoetis (ZTS) Stock Forecast, Price & News

$173.98
-0.03 (-0.02%)
(As of 09/29/2023 06:40 PM ET)
Compare
Today's Range
$173.79
$175.59
50-Day Range
$173.95
$192.77
52-Week Range
$124.15
$194.99
Volume
1.50 million shs
Average Volume
1.96 million shs
Market Capitalization
$80.09 billion
P/E Ratio
36.55
Dividend Yield
0.86%
Price Target
$222.44

Zoetis MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
27.9% Upside
$222.44 Price Target
Short Interest
Healthy
0.76% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-4.66
Upright™ Environmental Score
News Sentiment
0.88mentions of Zoetis in the last 14 days
Based on 23 Articles This Week
Insider Trading
Selling Shares
$4.69 M Sold Last Quarter
Proj. Earnings Growth
11.44%
From $5.42 to $6.04 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.86 out of 5 stars

Medical Sector

58th out of 968 stocks

Pharmaceutical Preparations Industry

14th out of 452 stocks


ZTS stock logo

About Zoetis (NYSE:ZTS) Stock

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

ZTS Price History

ZTS Stock News Headlines

Zoetis (NYSE:ZTS) Raised to "Strong-Buy" at StockNews.com
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
How is This "Hidden Gem" Thriving in a Turbulent Market?
While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.
Zoetis Is An Impressive Healthcare Compounder
Zoetis (NYSE:ZTS) Rating Lowered to Buy at StockNews.com
25 Best Dog Breeds for Children and Families
Is Zoetis (NYSE:ZTS) Using Too Much Debt?
What 5 Analyst Ratings Have To Say About Zoetis
A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)
Why Is Zoetis (ZTS) Down 1.3% Since Last Earnings Report?
See More Headlines
Receive ZTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zoetis and its competitors with MarketBeat's FREE daily newsletter.

ZTS Company Calendar

Ex-Dividend for 9/1 Dividend
7/20/2023
Last Earnings
8/08/2023
Dividend Payable
9/01/2023
Today
10/02/2023
Next Earnings (Confirmed)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
CUSIP
98978V10
Employees
13,800
Year Founded
2012

Price Target and Rating

Average Stock Price Forecast
$222.44
High Stock Price Forecast
$260.00
Low Stock Price Forecast
$200.00
Forecasted Upside/Downside
+27.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
9 Analysts

Profitability

Net Income
$2.11 billion
Pretax Margin
34.40%

Debt

Sales & Book Value

Annual Sales
$8.08 billion
Cash Flow
$5.93 per share
Book Value
$9.45 per share

Miscellaneous

Free Float
459,765,000
Market Cap
$80.09 billion
Optionable
Optionable
Beta
0.78

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Ms. Kristin C. PeckMs. Kristin C. Peck (Age 52)
    CEO & Director
    Comp: $2.8M
  • Mr. Wetteny N. JosephMr. Wetteny N. Joseph (Age 51)
    Exec. VP & CFO
    Comp: $1.26M
  • Ms. Wafaa Mamilli (Age 56)
    EVP, Chief Digital & Tech. Officer, Group Pres for China, Brazil and Preci. Animal Health
    Comp: $1.08M
  • Ms. Heidi C. ChenMs. Heidi C. Chen (Age 56)
    Exec. VP, Gen. Counsel, Corp. Sec. & Bus. Lead of Human Health Diagnostics
    Comp: $1.04M
  • Ms. Roxanne LaganoMs. Roxanne Lagano (Age 58)
    Exec. VP and Chief HR Officer & Global Operations
  • Mr. Steven Frank
    VP of Investor Relations
  • Mr. William Price
    VP & Chief Communications Officer
  • Dr. Robert J. Polzer Ph.D. (Age 54)
    Exec. VP and Pres of R&D
  • Ms. Jeannette Ferran Astorga (Age 48)
    Exec. VP of Corp. Affairs & Communications and Chief Sustainability Officer
  • Mr. Nick Ashton (Age 50)
    Exec. VP and Pres of Global Manufacturing & Supply













ZTS Stock - Frequently Asked Questions

Should I buy or sell Zoetis stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Zoetis in the last twelve months. There are currently 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ZTS shares.
View ZTS analyst ratings
or view top-rated stocks.

What is Zoetis' stock price forecast for 2023?

9 analysts have issued 1 year price targets for Zoetis' shares. Their ZTS share price forecasts range from $200.00 to $260.00. On average, they expect the company's share price to reach $222.44 in the next year. This suggests a possible upside of 27.9% from the stock's current price.
View analysts price targets for ZTS
or view top-rated stocks among Wall Street analysts.

How have ZTS shares performed in 2023?

Zoetis' stock was trading at $146.55 on January 1st, 2023. Since then, ZTS stock has increased by 18.7% and is now trading at $173.98.
View the best growth stocks for 2023 here
.

When is Zoetis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our ZTS earnings forecast
.

How can I listen to Zoetis' earnings call?

Zoetis will be holding an earnings conference call on Thursday, November 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Zoetis' earnings last quarter?

Zoetis Inc. (NYSE:ZTS) issued its quarterly earnings data on Tuesday, August, 8th. The company reported $1.41 earnings per share for the quarter, beating analysts' consensus estimates of $1.31 by $0.10. The firm had revenue of $2.18 billion for the quarter, compared to the consensus estimate of $2.16 billion. Zoetis had a net margin of 26.92% and a trailing twelve-month return on equity of 52.02%. The business's quarterly revenue was up 3.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.20 earnings per share.
Read the conference call transcript
.

How often does Zoetis pay dividends? What is the dividend yield for Zoetis?

Zoetis declared a quarterly dividend on Thursday, May 11th. Investors of record on Friday, July 21st will be given a dividend of $0.375 per share on Friday, September 1st. This represents a $1.50 annualized dividend and a yield of 0.86%. The ex-dividend date of this dividend is Thursday, July 20th.
Read our dividend analysis for ZTS
.

Is Zoetis a good dividend stock?

Zoetis (NYSE:ZTS) pays an annual dividend of $1.50 per share and currently has a dividend yield of 0.86%. The company has been increasing its dividend for 9 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 31.51%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ZTS will have a dividend payout ratio of 24.83% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ZTS.

What guidance has Zoetis issued on next quarter's earnings?

Zoetis updated its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of $5.37-$5.47 for the period, compared to the consensus EPS estimate of $5.40. The company issued revenue guidance of $8.50 billion-$8.65 billion, compared to the consensus revenue estimate of $8.63 billion.

What is Kristin Peck's approval rating as Zoetis' CEO?

50 employees have rated Zoetis Chief Executive Officer Kristin Peck on Glassdoor.com. Kristin Peck has an approval rating of 82% among the company's employees. 70.0% of employees surveyed would recommend working at Zoetis to a friend.

What other stocks do shareholders of Zoetis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zoetis investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Hawkins (HWKN), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Micron Technology (MU), Accenture (ACN) and Transocean (RIG).

What is Zoetis' stock symbol?

Zoetis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZTS."

How do I buy shares of Zoetis?

Shares of ZTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zoetis' stock price today?

One share of ZTS stock can currently be purchased for approximately $173.98.

How much money does Zoetis make?

Zoetis (NYSE:ZTS) has a market capitalization of $80.09 billion and generates $8.08 billion in revenue each year. The company earns $2.11 billion in net income (profit) each year or $4.76 on an earnings per share basis.

How many employees does Zoetis have?

The company employs 13,800 workers across the globe.

Does Zoetis have any subsidiaries?
The following companies are subsidiares of Zoetis: Abaxis, Abaxis Asia Limited, Abaxis Europe GmbH, Abaxis Inc., Abaxis South East Europe d. o.o., Abaxis UK Limited, Alpharma Animal Health Company, Alpharma Animal Health Hong Kong Co. Limited, Alpharma Bermuda LLC, Alpharma Euro Holdings LLC, Alpharma Holdings Barbados SRL, Alpharma LLC, Alpharma Luxembourg S.A.R.L. y Compania Limitada, Alpharma do Brasil Ltda., Bovigen, Catapult Genetics Pty Ltd, Continental Farmaceutica SPRL, Cross Vetpharm Group Limited, Embrex LLC, Ethos Diagnostic Science, Fish Vet Group, Fish Vet Group Limited, Jilin Zoetis Guoyuan Animal Health Co. Ltd., Jorox Pty, King Animal Health, Microtek International Inc, Mikjan Corporation, Nexvet, Nexvet Australia Pty Ltd, PAH 7V6 Holding Limited, PAH CHHK Holding B.V., PAH India Holdco LLC, PAH India Holding 1 B.V., PAH Netherlands 2 B.V., PAH Oceania B.V., PAH Spain S.L., PHARMAQ, PT Zoetis Animalhealth Indonesia, Performance Livestock Analytics, Performance Livestock Analytics Inc., Pharmaq AS Chile Limitada, Pharmaq AS Service SpA, Pharmaq AS., Pharmaq Analytiq AS, Pharmaq Analytiq Limited, Pharmaq Analytiq SpA, Pharmaq Fishteq AS, Pharmaq Fishteq SpA, Pharmaq Ltd, Pharmaq Spain Aqua SL, Pharmaq Veterinar Ecza Deposu ve su Urunleri Ticaret Ltd Ski, Pharmaq Vietnam Company Limited, Phoenix Central Laboratory for Veterinarians Inc., Phoenix Lab, Platinum Performance, Platinum Performance Inc., Pumpkin Holdings Inc., Pumpkin Insurance Services Inc., Scandinavian Micro Biodevices, Smartbow GmbH, Smartbow RUS OOO, Synbiotics Corporation, Synbiotics LLC, Vetnex Animal Health Ltd, Virtual Recall, Virtual Recall Limited, Virtual Recall Pty Ltd, ZNLabs, ZNLabs LLC, ZOETISECUADOR Cia. Ltda., Zoetis Animal Health ApS, Zoetis Argentina S.R.L., Zoetis Australia Pty Ltd, Zoetis Australia Research & Manufacturing Pty Ltd, Zoetis B.V., Zoetis Belgium S.A., Zoetis Biopharmaceutical Co. Ltd, Zoetis Broomhill IP Limited, Zoetis Broomhill Property Limited, Zoetis C.A., Zoetis Canada Inc., Zoetis Colombia S.A.S., Zoetis Costa Rica S.R.L., Zoetis Denmark ApS, Zoetis Deutschland GmbH, Zoetis Egypt LLC, Zoetis Egypt Pharmaceuticals LLC, Zoetis Egypt Trading LLC, Zoetis Enterprise Management Shanghai Co. Ltd., Zoetis Finland Oy, Zoetis France, Zoetis Hayvan Sagligi Ltd. Sti., Zoetis Hellas S.A., Zoetis Holdings LLC, Zoetis Hungary Kft., Zoetis Import Egypt LLC, Zoetis India Limited, Zoetis Indústria de Produtos Veterinários Ltda., Zoetis International Holdings B.V., Zoetis Israël Holding B.V., Zoetis Italia S.r.l., Zoetis Japan K.K., Zoetis Korea Ltd., Zoetis LLC, Zoetis Luxembourg Holding S.à r.l., Zoetis Malaysia Sdn. Bhd., Zoetis Manufacturing & Research Spain S.L., Zoetis Manufacturing Italia S.R.L., Zoetis Medolla Manufacturing S.R.L., Zoetis Mexico S. de R.L. de C.V., Zoetis Netherlands 1 B.V., Zoetis Netherlands 3 B.V., Zoetis Netherlands 4 B.V., Zoetis Netherlands 5 B.V., Zoetis New Zealand Limited, Zoetis OOO, Zoetis Overseas Holding B.V., Zoetis Overseas Services Inc., Zoetis Panama S. de R.L., Zoetis Pharmaceutical Research Private Limited, Zoetis Philippines Inc., Zoetis Polska sp. z o.o, Zoetis Portugal Lda., Zoetis Products Inc., Zoetis Reference Laboratories China Co. Ltd., Zoetis Reference Labs LLC, Zoetis Romania SRL, Zoetis S.R.L., Zoetis Salud Animal de Bolivia S.A., Zoetis Schweiz GmbH, Zoetis Services LLC, Zoetis Singapore Pte. Ltd., Zoetis South Africa Pty Ltd., Zoetis Spain S.L., Zoetis Subsidiary Holdings Inc., Zoetis Suzhou Manufacturing Co. Ltd., Zoetis Sweden AB, Zoetis Taiwan Limited, Zoetis Thailand Limited, Zoetis Treasury Center BV, Zoetis UK Limited, Zoetis US LLC, Zoetis Ukraine LLC, Zoetis Vietnam Limited Liability Company, Zoetis WLC LLC, Zoetis Weesp B.V., Zoetis Yantai Manufacturing Co. Ltd., Zoetis de Chile S.A., Zoetis de Uruguay S.R.L., Zoetis Österreich GmbH, and Zoetis Česká republika s.r.o..
Read More
How can I contact Zoetis?

Zoetis' mailing address is 10 Sylvan Way, Parsippany NJ, 07054. The official website for the company is www.zoetis.com. The company can be reached via phone at (973) 822-7000, via email at steve.frank@zoetis.com, or via fax at 302-655-5049.

This page (NYSE:ZTS) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -